CustoMED Secures $6M in Funding to Advance AI-Driven Orthopedic Care Solutions

Gene editing therapy companies, including CRISPR Therapeutics, Editas Medicines, and Intellia Therapeutics, are trading higher after a report that the US FDA will streamline its approval process for these medicines. This could make it easier for these companies to gain approval for their gene editing therapies.